Menu Back toSession-4-Clinical-Trial-Safety-Regulations-US-IND-Safety-Reporting

Drug Safety and Pharmacovigilance Across the Product Lifecycle

Build a solid foundation in the key concepts of drug safety and pharmacovigilance throughout the medical product development lifecycle. Learn how to comply with regulatory requirements.


Session 4: Clinical Trial Safety Regulations – US IND Safety Reporting

Session Chair(s)

Jill W. Buckley, PharmD

Jill W. Buckley, PharmD

  • Adjunct Assistant Professor
  • Rutgers, the State University of New Jersey, United States
This session will cover the FDA requirements for safety reporting for clinical trials.

Contact us

Registration Questions?

Send Email
1.888.257.6457
+1.215.442.6100


Agenda and Event Logistics

Send Email
+1.215.442.6108